Nectar Lifesciences Buyback 2025 vs Puretrop Fruits Buyback 2026

Comparison between Nectar Lifesciences Buyback 2025 and Puretrop Fruits Buyback 2026.

Buyback Details

Nectar Lifesciences Buyback 2025 is a Tender Offer buyback proposed to list at BSE, NSE while Puretrop Fruits Buyback 2026 is a Tender Offer proposed to list at BSE.

 Nectar Lifesciences Ltd.Puretrop Fruits Ltd
LogoNectar Lifesciences Buyback 2025 LogoPuretrop Fruits Buyback 2026 Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSEBSE
Face Value₹1 per share₹10 per share
Buyback Price₹27 per share₹200 per share
Issue Size3,00,00,000 shares11,00,000 shares
Issue Size (Amount)₹81.00 Crores₹22.00 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders25 Equity Shares out of every 103 Fully paid-up Equity Shares held on the Record Date.1,32,51,651
General Category for all other Eligible Shareholders25 Equity Shares out of every 103 Fully paid-up Equity Shares held on the Record Date.1,67,48,349
CategoryEntitlement RatioShares Offered
Small Shareholders4 : 291,82,975
General Category4 : 299,17,025

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

RegistrarKfin Technologies Ltd.Bigshare Services Pvt.Ltd.
Lead ManagersMaster Capital Services Ltd.Vivro Financial Services Pvt.Ltd.
Necessity of the buyback
  • The buyback will help the company to return surplus cash to its shareholders holding equity shares broadly in proportion to their shareholding, thereby, enhancing the overall return to shareholders.
  • The buyback will help the company to optimize the capital structure;
  • The Buyback, which is being implemented through the Tender Offer route as prescribed under the SEBI Buyback Regulations, would involve allocation of the number of equity shares as per their entitlement or 15% of the number of equity shares to be bought back, whichever is higher, reserved. The company believes that the reservation for small shareholders would benefit a large number of the Company's public shareholders, who get classified as "Small Shareholders, as per regulations 2(i)(n) of the SEBI Buyback Regulations.
  • The buyback may help in improving financial ratios like earnings per share, return on capital employed, and return on equity, by reduction in the equity base, thereby leading to long-term increase in shareholders' vlaue; and
  • The buyback gives an option to the shareholders holding Equity shares of the company, who can choose to participate and get cash in lieu of Equity shares to be accepted under the Buyback offer or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the buyback offer, without additional investment.

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Optimise the Company’s capital structure.
  • Improve financial ratios such as earnings per share and return on equity.
  • Enhance long-term shareholder value.
  • Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

Buyback Timetable

Nectar Lifesciences Buyback 2025 and Puretrop Fruits Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Nectar Lifesciences Buyback 2025 Buyback record date is Dec 24, 2025. Puretrop Fruits Buyback 2026 Buyback record date is Apr 10, 2026.

 Nectar Lifesciences Ltd.Puretrop Fruits Ltd
Record DateDec 24, 2025Apr 10, 2026
Offer Open DateDec 31, 2025Apr 17, 2026
Offer Closure DateJan 06, 2026Apr 23, 2026
Last date for receipt of tender formsJan 06, 2026Apr 23, 2026
Finalisation of buybackJan 12, 2026Apr 29, 2026
Last Date for settlment of bidsJan 13, 2026Apr 30, 2026
Last Date for extinguishment of sharesJan 22, 2026May 12, 2026

Financial Details and Other Relevent Information

Comparison of Nectar Lifesciences Buyback 2025 and Puretrop Fruits Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Nectar Lifesciences Ltd.Puretrop Fruits Ltd
Financial

Company Financials (Restated Consolidated)

Nectar Lifesciences Ltd.'s revenue decreased by 1% and profit after tax (PAT) dropped by 2376% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Total Income11.301,674.971,698.661,566.85
Profit After Tax-1.01-113.684.99-24.18
NET Worth716.87956.111,069.251,064.59
Reserves and Surplus694.44933.681,046.821,042.17
Total Borrowing458.85582.02635.54753.83
Amount in ₹ Crore

Company Financials (Restated)

Period Ended30 Sep 202531 Mar 202531 Mar 2024
Total Income56.48114.27109.29
Profit After Tax18.8411.8759.95
NET Worth126.29107.47138.79
Reserves and Surplus118.3299.50128.90
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2025 16.99 13.75 14.67
Oct-2025 16.01 13.31 14.26
Sep-2025 17.03 14.07 15.15

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2026 183.00 180.20 181.60
Jan-2026 183.95 150.85 167.40
Dec-2025 167.70 147.00 157.35
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2025 16.99 13.71 14.64
Oct-2025 15.76 13.10 14.18
Sep-2025 16.99 14.03 15.12

Compare with others

Compare:

Nectar Lifesciences Buyback 2025 and Puretrop Fruits Buyback 2026